Home > Quotes > COV

Covidien plc. Stock Quote & Summary Data

Get COV Alerts
*Delayed - data as of Dec. 22, 2014 14:31 ET  -  Find a broker to begin trading COV now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    COV Real Time
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
1 Year Target: 94.11
Today's High/Low:  / 
Share Volume:
90 Day Avg. Daily Volume This is the average share volume for the past 50 trading days, for NASDAQ stocks and 90 trading days for Non-NASDAQ stocks. This field allows you to compare today's trading to the average daily volume. 4,377,322
Previous Close: $ 102.90
52 Week High /Low: $ 103.90 / $ 65.97
Market cap “Market Capitalization” is a measure of the estimated value of the common equity securities of the company or their equivalent. It does not include securities convertible into the common equity securities. “Market Capitalization” is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable). NASDAQ does not use this value to determine compliance with the listing requirements. $ 46,926,529,096
P/E Ratio: 28.47
Forward P/E(1y) A widely used stock evaluation measure. For a security, the Price/Earnings Ratio is given by dividing the Last Sale Price by the Average EPS (Earnings Per Share) Estimate for the specified fiscal time period. The forward P/E refers to the value for the next full year. 23.71
Earnings Per Share (EPS) The EPS listed on our infoquote and Summary Quote page is "12-mos Rolling". EPS represents the portion of a company's profit allocated to each outstanding share of common stock. Net income (reported or estimated) for a period of time is divided by the total number of shares outstanding (TSO) during that period; See growth rate measures for EPS. Our vendor's methodology for the EPS on the infoquote and Summary Quote pages follows the EPS used by the majority of the analysts following the stock, in many cases this is EBITDA EPS. $ 3.64
Annualized dividend $ 1.44
Ex Dividend Date Oct. 3, 2014
Dividend Payment Date Nov. 6, 2014
Current Yield 1.4 %
Beta 0

Intraday Chart

ETFs with COV as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
7.37% iShares U.S. Medical Devices ETF (IHI) +11.74  (11.36%)
2.51% First Trust Capital Strength ETF (FTCS) +3.61  (10.32%)
2.27% Guggenheim S&P 500 Equal Weight Healthcare ETF (RYH) +18.56  (14.62%)
2.1% SPDR S&P Health Care Equipment (XHE) +8.11  (10.22%)
0.83% Guggenheim Raymond James SB-1 Equity Fund (RYJ) +0.69  (2.00%)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.

Company Description (as filed with the SEC)

We are a global leader in the development, manufacture and sale of healthcare products for use in clinical and home settings. Our products are found in almost every hospital in the United States, and we have a significant and growing presence in non-U.S. markets. Our mission is to create and deliver innovative healthcare solutions, developed in ethical collaboration with medical professionals, which enhance the quality of life for patients and improve outcomes for our customers and our shareholders. Business Segments Our reportable segments are as follows: • Medical Devices includes the development, manufacture and sale of endomechanical instruments, energy devices, soft tissue repair products, vascular products, oximetry and monitoring products, airway and ventilation products and other medical products.  ... More ...  

News for COV

Consensus Recommendation

Research Brokers before you trade

Want to trade FX?